NCT01913808 - Comparing Intravenous and Oral Iron in Postoperative Anemia | Biotech Hunter

Enrollment

122

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

January 31, 2013

Conditions

Postoperative AnemiaOsteoarthritis, Knee

Interventions

DRUG

Ferric carboxymaltose

Single intravenous dose ferric carboxymaltose

DRUG

ferrous glycine sulphate

Daily oral dose of 100 mg iron (ferrous glycine sulphate)

Trial Locations (1)

Hospital de la Esperanza (Parc de Salut MAR), Barcelona